Enliven Therapeutics (ELVN) Q3 2023 Earnings

9NovConfirmed
Q4 2022
Q1 2023
Q2 2023
Q3 2023
-0.79
-0.12
0.54
1.21

Details

Expected EPS
-0.47
Actual EPS
-0.51
Surprise EPS
-0.04
Surprise Percent
+8.51%

Description

Enliven Therapeutics (ELVN) has reported earnings of -0.51 per share for Q3 2023.

0 Comments

Share your thoughts